New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in Diabetologia (the journal of EASD) ...

The development of a safe, effective rotavirus vaccine was a major milestone in reducing hospitalizations and deaths from the virus in children around the globe, but the rollout of the first rotavirus ...

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in Diabetologia shows that the incidence (the ...

Two doses of the monovalent rotavirus vaccine (RV1, Rotarix, GlaxoSmithKline) is more than 90% effective at preventing severe rotavirus-associated gastroenteritis, putting the vaccine’s efficacy on ...

The Department of Health and Human Services has removed the rotavirus vaccine, along with five others, from the list of universally recommended childhood immunizations. This makes the U.S. an outlier.

Risk factors for not initiating a rotavirus vaccine (RVV)—for which the first dose is recommended by a maximum age of 14 weeks, six days—include extremely preterm birth and having no health insurance, ...

Researchers found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, strongly suggesting that giving the rotavirus ...

When Paul Offit, MD, was a pediatric resident at the Children's Hospital of Pittsburgh in the late 1970s, some 400 children were admitted each winter with severe dehydration from rotavirus infection.

Researchers have shown that differences in the entire rotavirus genome -- not just its two surface proteins -- affect how well vaccines work, helping to explain why some strains are more likely to ...

Rotavirus remains one of the most formidable viral pathogens of early childhood, and a new hospital-based study from Addis ...